My Cart [ 0 ]
Home > Antibodies > Research-Grade Biosimilars > Mirvetuximab Biosimilar, FOLR1 Monoclonal Antibody

Mirvetuximab Biosimilar, FOLR1 Monoclonal Antibody

Folate Receptor alpha, Folate Receptor 1, Folate Receptor alpha, Folate Binding Protein, FBP

Catalog No. Product Name Size List Price (US$) Quantity
C059P Mirvetuximab Biosimilar, Human FOLR1 Monoclonal Antibody 1 mg 175.00
C059P Mirvetuximab Biosimilar, Human FOLR1 Monoclonal Antibody 5 mg 480.00
C059P Mirvetuximab Biosimilar, Human FOLR1 Monoclonal Antibody 20 mg 960.00
Description

C059P: Mirvetuximab Biosimilar, Human FOLR1 Monoclonal Antibody

Recombinant Humanized IgG1 Monoclonal Antibody.
Isotype: Human IgG1 kappa.
Source: The monoclonal antibody mirvetuximab biosimilar was produced in mammalian cells.
Specificity/Sensitivity: The monoclonal antibody mirvetuximab biosimilar specifically binds to the human FOLR1 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by mirvetuximab.
Form of Antibody: 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives.
Endotoxin: < 1 EU per 1 mg of the protein by the LAL method.
Purity: >95% by SDS-PAGE under reducing conditions and HPLC.

Shipping: The monoclonal antibody mirvetuximab is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
12 months from date of receipt, 2 to 8°C as supplied.
 

Background

What is Mirvetuximab biosimilar research grade? Mirvetuximab biosimilar uses the same protein sequences as the therapeutic antibody Mirvetuximab. Mirvetuximab soravtansine is used as a treatment for epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. Mirvetuximab soravtansine is a folate receptor alpha (FRa)-directed antibody and microtubule inhibitor conjugate.

Syd Labs provides the following research grade antibody biosimilars used in ADCs:
Tusamitamab biosimilar, research grade, anti-human CEACAM5 monoclonal antibody
Rovalpituzumab biosimilar, research grade, anti-human DLL3 monoclonal antibody
Trastuzumab biosimilar, research grade, anti-human HER2 monoclonal antibody
Cofetuzumab biosimilar, research grade, anti-human PTK7 monoclonal antibody
Ifinatamab biosimilar, research grade, anti-human B7-H3 (CD276) monoclonal antibody
Sacituzumab biosimilar, research grade, anti-human Trop-2 monoclonal antibody
Gemtuzumab biosimilar, research grade, anti-human CD33 monoclonal antibody
Polatuzumab biosimilar, research grade, anti-human CD79B monoclonal antibody
Cetuximab biosimilar, research grade, anti-human EGFR monoclonal antibody

Related Links

See our Privacy Policy